Quantitative proteomics suggests decrease in the secretogranin-1 cerebrospinal fluid levels during the disease course of multiple sclerosis

A.C. Kroksveen, J.D. Jaffe, E. Aasebo, H. Barsnes, Y. Bjorlykke, D. Franciotta, H. Keshishian, K.M. Myhr, J.A. Opsahl, V. van Pesch, C.E. Teunissen, O. Torkildsen, R.J. Ulvik, H. Vethe, S.A. Carr, F.S. Berven

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)3361-3369
JournalProteomics
Volume15
Issue number19
DOIs
Publication statusPublished - 2015

Cite this

Kroksveen, A. C., Jaffe, J. D., Aasebo, E., Barsnes, H., Bjorlykke, Y., Franciotta, D., ... Berven, F. S. (2015). Quantitative proteomics suggests decrease in the secretogranin-1 cerebrospinal fluid levels during the disease course of multiple sclerosis. Proteomics, 15(19), 3361-3369. https://doi.org/10.1002/pmic.201400142